Estimating hip fracture morbidity, mortality and costs

被引:677
作者
Braithwaite, RS
Col, NF
Wong, JB
机构
[1] Univ Pittsburgh, Montefiore Med Ctr, Div Gen Internal Med, Sect Decis Sci & Clin Syst Modeling,Dept Med,Sch, Pittsburgh, PA 15213 USA
[2] Harvard Univ, Sch Med, Dept Med, Decis Syst Grp,Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Tufts Univ, Div Clin Decis Making Informat & Telemed, New England Med Ctr, Dept Med,Sch Med,Tupper Res Inst, Boston, MA 02111 USA
关键词
hip fracture; cost; decision analysis; morbidity; mortality; nursing home;
D O I
10.1046/j.1532-5415.2003.51110.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: To estimate lifetime morbidity, mortality, and costs from hip fracture incorporating the effect of deficits in activities of daily living. DESIGN: Markov computer cohort simulation considering short- and long-term outcomes attributable to hip fractures. Data estimates were based on published literature, and costs were based primarily on Medicare reimbursement rates. SETTING: Postacute hospital facility. PARTICIPANTS: Eighty-year-old community dwellers with hip fractures. MEASUREMENTS: Life expectancy, nursing facility days, and costs. RESULTS: Hip fracture reduced life expectancy by 1.8 years or 25% compared with an age- and sex-matched general population. About 17% of remaining life was spent in a nursing facility. The lifetime attributable cost of hip fracture was $81,300, of which nearly half (44%) related to nursing facility expenses. The development of deficits in ADLs after hip fracture resulted in substantial morbidity, mortality, and costs. CONCLUSION: Hip fractures result in significant mortality, morbidity, and costs. The estimated lifetime cost for all hip fractures in the United States in 1997 likely exceeded $20 billion. These results emphasize the importance of current and future interventions to decrease the incidence of hip fracture.
引用
收藏
页码:364 / 370
页数:7
相关论文
共 64 条
  • [1] *AM AC ORTH SURG, 1992, MUSC COND US
  • [2] Beck T S, 1996, Am J Orthop (Belle Mead NJ), V25, P608
  • [3] Supplemental calcium for the prevention of hip fracture: Potential health-economic benefits
    Bendich, A
    Leader, S
    Muhuri, P
    [J]. CLINICAL THERAPEUTICS, 1999, 21 (06) : 1058 - 1072
  • [4] A COMPARISON OF STATISTICAL-METHODS FOR COMBINING EVENT RATES FROM CLINICAL-TRIALS
    BERLIN, JA
    LAIRD, NM
    SACKS, HS
    CHALMERS, TC
    [J]. STATISTICS IN MEDICINE, 1989, 8 (02) : 141 - 151
  • [5] FACTORS ASSOCIATED WITH SHORT-TERM VERSUS LONG-TERM SKILLED NURSING FACILITY PLACEMENT AMONG COMMUNITY-LIVING HIP FRACTURE PATIENTS
    BONAR, SK
    TINETTI, ME
    SPEECHLEY, M
    COONEY, LM
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1990, 38 (10) : 1139 - 1144
  • [6] The economic cost of hip fractures in community-dwelling older adults: A prospective study
    Brainsky, A
    Glick, H
    Lydick, E
    Epstein, R
    Fox, KM
    Hawkes, W
    Kashner, TM
    Zimmerman, SI
    Magaziner, J
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (03) : 281 - 287
  • [7] HIP FRACTURE - A PROSPECTIVE-STUDY OF HOSPITAL COURSE, COMPLICATIONS, AND COSTS
    CAMPION, EW
    JETTE, AM
    CLEARY, PD
    HARRIS, BA
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1987, 2 (02) : 78 - 82
  • [8] COSTS AND HEALTH-EFFECTS OF OSTEOPOROTIC FRACTURES
    CHRISCHILLES, E
    SHIREMAN, T
    WALLACE, R
    [J]. BONE, 1994, 15 (04) : 377 - 386
  • [9] The effect of alendronate on fracture-related healthcare utilization and costs: The fracture intervention trial
    Chrischilles, EA
    Dasbach, EJ
    Rubenstein, LM
    Cook, JR
    Tabor, HK
    Black, DM
    [J]. OSTEOPOROSIS INTERNATIONAL, 2001, 12 (08) : 654 - 660
  • [10] TARGETED ESTROGEN PROGESTOGEN REPLACEMENT THERAPY FOR OSTEOPOROSIS - CALCULATION OF HEALTH-CARE COST SAVINGS
    CLARK, AP
    SCHUTTINGA, JA
    [J]. OSTEOPOROSIS INTERNATIONAL, 1992, 2 (04) : 195 - 200